Exact Sciences investing $350 million in Madison facilities, to create $1,300 jobs

view original post

MADISON (WKOW) — Exact Sciences is investing $350 million into its Madison campuses, a move that company leaders suggest will create 1,300 new jobs.

Exact Sciences, which relocated to Wisconsin in 2009, is a cancer screening and diagnostic company best known for a noninvasive colorectal cancer screening test. 

“Continued investments in our Wisconsin-based people and facilities will accelerate the development of new cancer tests and ensure we continue providing world-class service and critical answers to patients,”  said Kevin Conroy, chairman and CEO of Exact Sciences.

The company plans to expand its west-side Madison campus through three categories: research and development, laboratory space, and warehouse space. The expansions are expected to support the company’s ability to enhance current cancer screening products and develop new ones. 

Wisconsin Economic Development Corporation supports Exact Sciences’ Wisconsin based projects with an additional $18.5 million in performance based Enterprise Zone tax credits. The company will be awarded the credits if it meets capital investment and job creation goals by 2025.